| Source HCPCS Code |
|
Target NDC Code |
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
00004-0800-85
TAMIFLU (BLISTER PACK) 75 MG
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
00004-0810-95
TAMIFLU (TUTTI FRUTTI) 12 MG/ML
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
49999-0298-10
TAMIFLU 75 MG
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
52959-0801-10
TAMIFLU 75 MG
|
| Detail Information |
| Relationship Start Date |
2/23/2005 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
54569-4888-00
TAMIFLU (BLISTER PACK) 75 MG
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
54569-5615-00
TAMIFLU (TUTTI FRUTTI) 12 MG/ML
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
54868-4476-00
TAMIFLU 75 MG
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
54868-4684-00
TAMIFLU (TUTTI FRUTTI) 12 MG/ML
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
55045-2759-01
TAMIFLU 75 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2005 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
DP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
55887-0755-10
TAMIFLU 75 MG
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
57866-8002-01
TAMIFLU 75 MG
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
G9035
OSELTAMIVIR PHOSPHATE, ORAL, BRAND, PER 75 MG (FOR USE IN A MEDICARE APPROVED DEMONSTRATION PROJECT)
|
⇄
|
63874-0098-10
TAMIFLU (BLISTER PACK) 75 MG
|
| Detail Information |
| Relationship Start Date |
12/1/2004 |
| Relationship End Date |
5/31/2005 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|